Intuitive Surgical Inc (ISRG)
375.01
-2.07
(-0.55%)
USD |
NASDAQ |
Apr 24, 16:00
376.46
+1.45
(+0.39%)
After-Hours: 20:00
Intuitive Surgical Research and Development Expense (Quarterly): 284.50M for March 31, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 284.50M |
| December 31, 2023 | 260.10M |
| September 30, 2023 | 249.40M |
| June 30, 2023 | 244.40M |
| March 31, 2023 | 244.90M |
| December 31, 2022 | 244.10M |
| September 30, 2022 | 217.10M |
| June 30, 2022 | 207.30M |
| March 31, 2022 | 210.50M |
| December 31, 2021 | 183.40M |
| September 30, 2021 | 165.50M |
| June 30, 2021 | 162.30M |
| March 31, 2021 | 159.80M |
| December 31, 2020 | 149.80M |
| September 30, 2020 | 155.00M |
| June 30, 2020 | 143.20M |
| March 31, 2020 | 147.10M |
| December 31, 2019 | 156.60M |
| September 30, 2019 | 135.90M |
| June 30, 2019 | 120.80M |
| March 31, 2019 | 144.00M |
| December 31, 2018 | 119.90M |
| September 30, 2018 | 107.60M |
| June 30, 2018 | 95.10M |
| March 31, 2018 | 95.50M |
| Date | Value |
|---|---|
| December 31, 2017 | 87.10M |
| September 30, 2017 | 83.40M |
| June 30, 2017 | 84.60M |
| March 31, 2017 | 73.50M |
| December 31, 2016 | 69.10M |
| September 30, 2016 | 62.60M |
| June 30, 2016 | 54.70M |
| March 31, 2016 | 53.20M |
| December 31, 2015 | 52.60M |
| September 30, 2015 | 51.00M |
| June 30, 2015 | 49.40M |
| March 31, 2015 | 44.40M |
| December 31, 2014 | 47.30M |
| September 30, 2014 | 47.50M |
| June 30, 2014 | 40.20M |
| March 31, 2014 | 43.00M |
| December 31, 2013 | 41.70M |
| September 30, 2013 | 43.20M |
| June 30, 2013 | 41.20M |
| March 31, 2013 | 41.60M |
| December 31, 2012 | 41.70M |
| September 30, 2012 | 49.70M |
| June 30, 2012 | 40.20M |
| March 31, 2012 | 38.40M |
| December 31, 2011 | 41.40M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
120.80M
Minimum
Jun 2019
284.50M
Maximum
Mar 2024
192.08M
Average
174.45M
Median
Research and Development Expense (Quarterly) Benchmarks
| Abbott Laboratories | 684.00M |
| Boston Scientific Corp | 363.00M |
| Stryker Corp | 350.00M |
| Globus Medical Inc | 52.25M |
| Zimmer Biomet Holdings Inc | 113.30M |